Q6YHK3: CD109 antigen
Protein names | - CD109 antigen - 150 kDa TGF-beta-1-binding protein - C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7 - Platelet-specific Gov antigen - p180 - r150 - CD109 |
---|---|
Gene names | CD109 |
Organism | Homo sapiens |
Protease Family | |
Protease ID | I39.006 |
Chromosome location | |
UniProt ID | Q6YHK3 |
6
N-termini
4
C-termini
2
Cleavages
0
Substrates
Sequence
10 20 30 40 50 60
MQGPPLLTAA HLLCVCTAAL AVAPGPRFLV TAPGIIRPGG NVTIGVELLE HCPSQVTVKA
70 80 90 100 110 120
ELLKTASNLT VSVLEAEGVF EKGSFKTLTL PSLPLNSADE IYELRVTGRT QDEILFSNST
130 140 150 160 170 180
RLSFETKRIS VFIQTDKALY KPKQEVKFRI VTLFSDFKPY KTSLNILIKD PKSNLIQQWL
190 200 210 220 230 240
SQQSDLGVIS KTFQLSSHPI LGDWSIQVQV NDQTYYQSFQ VSEYVLPKFE VTLQTPLYCS
250 260 270 280 290 300
MNSKHLNGTI TAKYTYGKPV KGDVTLTFLP LSFWGKKKNI TKTFKINGSA NFSFNDEEMK
310 320 330 340 350 360
NVMDSSNGLS EYLDLSSPGP VEILTTVTES VTGISRNVST NVFFKQHDYI IEFFDYTTVL
370 380 390 400 410 420
KPSLNFTATV KVTRADGNQL TLEERRNNVV ITVTQRNYTE YWSGSNSGNQ KMEAVQKINY
430 440 450 460 470 480
TVPQSGTFKI EFPILEDSSE LQLKAYFLGS KSSMAVHSLF KSPSKTYIQL KTRDENIKVG
490 500 510 520 530 540
SPFELVVSGN KRLKELSYMV VSRGQLVAVG KQNSTMFSLT PENSWTPKAC VIVYYIEDDG
550 560 570 580 590 600
EIISDVLKIP VQLVFKNKIK LYWSKVKAEP SEKVSLRISV TQPDSIVGIV AVDKSVNLMN
610 620 630 640 650 660
ASNDITMENV VHELELYNTG YYLGMFMNSF AVFQECGLWV LTDANLTKDY IDGVYDNAEY
670 680 690 700 710 720
AERFMEENEG HIVDIHDFSL GSSPHVRKHF PETWIWLDTN MGYRIYQEFE VTVPDSITSW
730 740 750 760 770 780
VATGFVISED LGLGLTTTPV ELQAFQPFFI FLNLPYSVIR GEEFALEITI FNYLKDATEV
790 800 810 820 830 840
KVIIEKSDKF DILMTSNEIN ATGHQQTLLV PSEDGATVLF PIRPTHLGEI PITVTALSPT
850 860 870 880 890 900
ASDAVTQMIL VKAEGIEKSY SQSILLDLTD NRLQSTLKTL SFSFPPNTVT GSERVQITAI
910 920 930 940 950 960
GDVLGPSING LASLIRMPYG CGEQNMINFA PNIYILDYLT KKKQLTDNLK EKALSFMRQG
970 980 990 1000 1010 1020
YQRELLYQRE DGSFSAFGNY DPSGSTWLSA FVLRCFLEAD PYIDIDQNVL HRTYTWLKGH
1030 1040 1050 1060 1070 1080
QKSNGEFWDP GRVIHSELQG GNKSPVTLTA YIVTSLLGYR KYQPNIDVQE SIHFLESEFS
1090 1100 1110 1120 1130 1140
RGISDNYTLA LITYALSSVG SPKAKEALNM LTWRAEQEGG MQFWVSSESK LSDSWQPRSL
1150 1160 1170 1180 1190 1200
DIEVAAYALL SHFLQFQTSE GIPIMRWLSR QRNSLGGFAS TQDTTVALKA LSEFAALMNT
1210 1220 1230 1240 1250 1260
ERTNIQVTVT GPSSPSPVKF LIDTHNRLLL QTAELAVVQP TAVNISANGF GFAICQLNVV
1270 1280 1290 1300 1310 1320
YNVKASGSSR RRRSIQNQEA FDLDVAVKEN KDDLNHVDLN VCTSFSGPGR SGMALMEVNL
1330 1340 1350 1360 1370 1380
LSGFMVPSEA ISLSETVKKV EYDHGKLNLY LDSVNETQFC VNIPAVRNFK VSNTQDASVS
1390 1400 1410 1420 1430 1440
IVDYYEPRRQ AVRSYNSEVK LSSCDLCSDV QGCRPCEDGA SGSHHHSSVI FIFCFKLLYF
MELWL
Isoforms
- Isoform 2 of CD109 antigen - Isoform 3 of CD109 antigen - Isoform 4 of CD109 antigenSequence View
10 20 30 40 50 60
MQGPPLLTAA HLLCVCTAAL AVAPGPRFLV TAPGIIRPGG NVTIGVELLE HCPSQVTVKA
70 80 90 100 110 120
ELLKTASNLT VSVLEAEGVF EKGSFKTLTL PSLPLNSADE IYELRVTGRT QDEILFSNST
130 140 150 160 170 180
RLSFETKRIS VFIQTDKALY KPKQEVKFRI VTLFSDFKPY KTSLNILIKD PKSNLIQQWL
190 200 210 220 230 240
SQQSDLGVIS KTFQLSSHPI LGDWSIQVQV NDQTYYQSFQ VSEYVLPKFE VTLQTPLYCS
250 260 270 280 290 300
MNSKHLNGTI TAKYTYGKPV KGDVTLTFLP LSFWGKKKNI TKTFKINGSA NFSFNDEEMK
310 320 330 340 350 360
NVMDSSNGLS EYLDLSSPGP VEILTTVTES VTGISRNVST NVFFKQHDYI IEFFDYTTVL
370 380 390 400 410 420
KPSLNFTATV KVTRADGNQL TLEERRNNVV ITVTQRNYTE YWSGSNSGNQ KMEAVQKINY
430 440 450 460 470 480
TVPQSGTFKI EFPILEDSSE LQLKAYFLGS KSSMAVHSLF KSPSKTYIQL KTRDENIKVG
490 500 510 520 530 540
SPFELVVSGN KRLKELSYMV VSRGQLVAVG KQNSTMFSLT PENSWTPKAC VIVYYIEDDG
550 560 570 580 590 600
EIISDVLKIP VQLVFKNKIK LYWSKVKAEP SEKVSLRISV TQPDSIVGIV AVDKSVNLMN
610 620 630 640 650 660
ASNDITMENV VHELELYNTG YYLGMFMNSF AVFQECGLWV LTDANLTKDY IDGVYDNAEY
670 680 690 700 710 720
AERFMEENEG HIVDIHDFSL GSSPHVRKHF PETWIWLDTN MGYRIYQEFE VTVPDSITSW
730 740 750 760 770 780
VATGFVISED LGLGLTTTPV ELQAFQPFFI FLNLPYSVIR GEEFALEITI FNYLKDATEV
790 800 810 820 830 840
KVIIEKSDKF DILMTSNEIN ATGHQQTLLV PSEDGATVLF PIRPTHLGEI PITVTALSPT
850 860 870 880 890 900
ASDAVTQMIL VKAEGIEKSY SQSILLDLTD NRLQSTLKTL SFSFPPNTVT GSERVQITAI
910 920 930 940 950 960
GDVLGPSING LASLIRMPYG CGEQNMINFA PNIYILDYLT KKKQLTDNLK EKALSFMRQG
970 980 990 1000 1010 1020
YQRELLYQRE DGSFSAFGNY DPSGSTWLSA FVLRCFLEAD PYIDIDQNVL HRTYTWLKGH
1030 1040 1050 1060 1070 1080
QKSNGEFWDP GRVIHSELQG GNKSPVTLTA YIVTSLLGYR KYQPNIDVQE SIHFLESEFS
1090 1100 1110 1120 1130 1140
RGISDNYTLA LITYALSSVG SPKAKEALNM LTWRAEQEGG MQFWVSSESK LSDSWQPRSL
1150 1160 1170 1180 1190 1200
DIEVAAYALL SHFLQFQTSE GIPIMRWLSR QRNSLGGFAS TQDTTVALKA LSEFAALMNT
1210 1220 1230 1240 1250 1260
ERTNIQVTVT GPSSPSPVKF LIDTHNRLLL QTAELAVVQP TAVNISANGF GFAICQLNVV
1270 1280 1290 1300 1310 1320
YNVKASGSSR RRRSIQNQEA FDLDVAVKEN KDDLNHVDLN VCTSFSGPGR SGMALMEVNL
1330 1340 1350 1360 1370 1380
LSGFMVPSEA ISLSETVKKV EYDHGKLNLY LDSVNETQFC VNIPAVRNFK VSNTQDASVS
1390 1400 1410 1420 1430 1440
IVDYYEPRRQ AVRSYNSEVK LSSCDLCSDV QGCRPCEDGA SGSHHHSSVI FIFCFKLLYF
MELWL
10 20 30 40 50 60
MQGPPLLTAA HLLCVCTAAL AVAPGPRFLV TAPGIIRPGG NVTIGVELLE HCPSQVTVKA
70 80 90 100 110 120
ELLKTASNLT VSVLEAEGVF EKGSFKTLTL PSLPLNSADE IYELRVTGRT QDEILFSNST
130 140 150 160 170 180
RLSFETKRIS VFIQTDKALY KPKQEVKFRI VTLFSDFKPY KTSLNILIKD PKSNLIQQWL
190 200 210 220 230 240
SQQSDLGVIS KTFQLSSHPI LGDWSIQVQV NDQTYYQSFQ VSEYVLPKFE VTLQTPLYCS
250 260 270 280 290 300
MNSKHLNGTI TAKYTYGKPV KGDVTLTFLP LSFWGKKKNI TKTFKINGSA NFSFNDEEMK
310 320 330 340 350 360
NVMDSSNGLS EYLDLSSPGP VEILTTVTES VTGISRNVST NVFFKQHDYI IEFFDYTTVL
370 380 390 400 410 420
KPSLNFTATV KVTRADGNQL TLEERRNNVV ITVTQRNYTE YWSGSNSGNQ KMEAVQKINY
430 440 450 460 470 480
TVPQSGTFKI EFPILEDSSE LQLKAYFLGS KSSMAVHSLF KSPSKTYIQL KTRDENIKVG
490 500 510 520 530 540
SPFELVVSGN KRLKELSYMV VSRGQLVAVG KQNSTMFSLT PENSWTPKAC VIVYYIEDDG
550 560 570 580 590 600
EIISDVLKIP VQLVFKNKIK LYWSKVKAEP SEKVSLRISV TQPDSIVGIV AVDKSVNLMN
610 620 630 640 650 660
ASNDITMENV VHELELYNTG YYLGMFMNSF AVFQECGLWV LTDANLTKDY IDGVYDNAEY
670 680 690 700 710 720
AERFMEENEG HIVDIHDFSL GSSPHVRKHF PETWIWLDTN MGYRIYQEFE VTVPDSITSW
730 740 750 760 770 780
VATGFVISED LGLGLTTTPV ELQAFQPFFI FLNLPYSVIR GEEFALEITI FNYLKDATEV
790 800 810 820 830 840
KVIIEKSDKF DILMTSNEIN ATGHQQTLLV PSEDGATVLF PIRPTHLGEI PITVTALSPT
850 860 870 880 890 900
ASDAVTQMIL VKAEGIEKSY SQSILLDLTD NRLQSTLKTL SFSFPPNTVT GSERVQITAI
910 920 930 940 950 960
GDVLGPSING LASLIRMPYG CGEQNMINFA PNIYILDYLT KKKQLTDNLK EKALSFMRQG
970 980 990 1000 1010 1020
YQRELLYQRE DGSFSAFGNY DPSGSTWLSA FVLRCFLEAD PYIDIDQNVL HRTYTWLKGH
1030 1040 1050 1060 1070 1080
QKSNGEFWDP GRVIHSELQG GNKSPVTLTA YIVTSLLGYR KYQPNIDVQE SIHFLESEFS
1090 1100 1110 1120 1130 1140
RGISDNYTLA LITYALSSVG SPKAKEALNM LTWRAEQEGG MQFWVSSESK LSDSWQPRSL
1150 1160 1170 1180 1190 1200
DIEVAAYALL SHFLQFQTSE GIPIMRWLSR QRNSLGGFAS TQDTTVALKA LSEFAALMNT
1210 1220 1230 1240 1250 1260
ERTNIQVTVT GPSSPSPVKF LIDTHNRLLL QTAELAVVQP TAVNISANGF GFAICQLNVV
1270 1280 1290 1300 1310 1320
YNVKASGSSR RRRSIQNQEA FDLDVAVKEN KDDLNHVDLN VCTSFSGPGR SGMALMEVNL
1330 1340 1350 1360 1370 1380
LSGFMVPSEA ISLSETVKKV EYDHGKLNLY LDSVNETQFC VNIPAVRNFK VSNTQDASVS
1390 1400 1410 1420 1430 1440
IVDYYEPRRQ AVRSYNSEVK LSSCDLCSDV QGCRPCEDGA SGSHHHSSVI FIFCFKLLYF
MELWL
10 20 30 40 50 60
MQGPPLLTAA HLLCVCTAAL AVAPGPRFLV TAPGIIRPGG NVTIGVELLE HCPSQVTVKA
70 80 90 100 110 120
ELLKTASNLT VSVLEAEGVF EKGSFKTLTL PSLPLNSADE IYELRVTGRT QDEILFSNST
130 140 150 160 170 180
RLSFETKRIS VFIQTDKALY KPKQEVKFRI VTLFSDFKPY KTSLNILIKD PKSNLIQQWL
190 200 210 220 230 240
SQQSDLGVIS KTFQLSSHPI LGDWSIQVQV NDQTYYQSFQ VSEYVLPKFE VTLQTPLYCS
250 260 270 280 290 300
MNSKHLNGTI TAKYTYGKPV KGDVTLTFLP LSFWGKKKNI TKTFKINGSA NFSFNDEEMK
310 320 330 340 350 360
NVMDSSNGLS EYLDLSSPGP VEILTTVTES VTGISRNVST NVFFKQHDYI IEFFDYTTVL
370 380 390 400 410 420
KPSLNFTATV KVTRADGNQL TLEERRNNVV ITVTQRNYTE YWSGSNSGNQ KMEAVQKINY
430 440 450 460 470 480
TVPQSGTFKI EFPILEDSSE LQLKAYFLGS KSSMAVHSLF KSPSKTYIQL KTRDENIKVG
490 500 510 520 530 540
SPFELVVSGN KRLKELSYMV VSRGQLVAVG KQNSTMFSLT PENSWTPKAC VIVYYIEDDG
550 560 570 580 590 600
EIISDVLKIP VQLVFKNKIK LYWSKVKAEP SEKVSLRISV TQPDSIVGIV AVDKSVNLMN
610 620 630 640 650 660
ASNDITMENV VHELELYNTG YYLGMFMNSF AVFQECGLWV LTDANLTKDY IDGVYDNAEY
670 680 690 700 710 720
AERFMEENEG HIVDIHDFSL GSSPHVRKHF PETWIWLDTN MGYRIYQEFE VTVPDSITSW
730 740 750 760 770 780
VATGFVISED LGLGLTTTPV ELQAFQPFFI FLNLPYSVIR GEEFALEITI FNYLKDATEV
790 800 810 820 830 840
KVIIEKSDKF DILMTSNEIN ATGHQQTLLV PSEDGATVLF PIRPTHLGEI PITVTALSPT
850 860 870 880 890 900
ASDAVTQMIL VKAEGIEKSY SQSILLDLTD NRLQSTLKTL SFSFPPNTVT GSERVQITAI
910 920 930 940 950 960
GDVLGPSING LASLIRMPYG CGEQNMINFA PNIYILDYLT KKKQLTDNLK EKALSFMRQG
970 980 990 1000 1010 1020
YQRELLYQRE DGSFSAFGNY DPSGSTWLSA FVLRCFLEAD PYIDIDQNVL HRTYTWLKGH
1030 1040 1050 1060 1070 1080
QKSNGEFWDP GRVIHSELQG GNKSPVTLTA YIVTSLLGYR KYQPNIDVQE SIHFLESEFS
1090 1100 1110 1120 1130 1140
RGISDNYTLA LITYALSSVG SPKAKEALNM LTWRAEQEGG MQFWVSSESK LSDSWQPRSL
1150 1160 1170 1180 1190 1200
DIEVAAYALL SHFLQFQTSE GIPIMRWLSR QRNSLGGFAS TQDTTVALKA LSEFAALMNT
1210 1220 1230 1240 1250 1260
ERTNIQVTVT GPSSPSPVKF LIDTHNRLLL QTAELAVVQP TAVNISANGF GFAICQLNVV
1270 1280 1290 1300 1310 1320
YNVKASGSSR RRRSIQNQEA FDLDVAVKEN KDDLNHVDLN VCTSFSGPGR SGMALMEVNL
1330 1340 1350 1360 1370 1380
LSGFMVPSEA ISLSETVKKV EYDHGKLNLY LDSVNETQFC VNIPAVRNFK VSNTQDASVS
1390 1400 1410 1420 1430 1440
IVDYYEPRRQ AVRSYNSEVK LSSCDLCSDV QGCRPCEDGA SGSHHHSSVI FIFCFKLLYF
MELWL
Protein Neighborhood
Domains & Features
6 N-termini - 4 C-termini - 2 Cleavages - 0 Substrates
N-termini
Name | Sequence | Position | Modification | Evidence type | Method | Source (database) | Source (Lab) | Evidence name | Publications (PMID) |
---|---|---|---|---|---|---|---|---|---|
Q6YHK3-1-unknown | MQGPPL... | 1 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt69846 | |||
Q6YHK3-1-unknown | MQGPPL... | 1 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt69847 | |||
Q6YHK3-1-unknown | MQGPPL... | 1 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt69848 | |||
Q6YHK3-22-unknown | VAPGPR... | 22 | inferred from electronic annotation | electronic annotation | UniProtKB | inferred from uniprot | |||
Q6YHK3-22-unknown | VAPGPR... | 22 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt112923 | |||
Q6YHK3-22-unknown | VAPGPR... | 22 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt112924 | |||
Q6YHK3-22-unknown | VAPGPR... | 22 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt112925 | |||
Q6YHK3-669-unknown | EGHIVD... | 669 | inferred from cleavage | unknown | TopFIND | Inferred from cleavage TC19644 | |||
Q6YHK3-669-unknown | EGHIVD... | 669 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt154495 | |||
Q6YHK3-669-unknown | EGHIVD... | 669 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt155539 | |||
Q6YHK3-670-unknown | GHIVDI... | 670 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt177312 | |||
Q6YHK3-670-unknown | GHIVDI... | 670 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt177311 | |||
Q6YHK3-670- | GHIVDI... | 670 | Subtiligase Based Positive Selection | Wells | apoptotic_RPMI_Dox | 23264352 | |||
Q6YHK3-1284-unknown | DVAVKE... | 1284 | inferred from cleavage | unknown | TopFIND | Inferred from cleavage TC19647 | |||
Q6YHK3-1284-unknown | DVAVKE... | 1284 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt157686 | |||
Q6YHK3-1284-unknown | DVAVKE... | 1284 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt157854 |
C-termini
Name | Sequence | Position | Evidence type | Method | Source (database) | Source (Lab) | Evidence name | Publications (PMIDs) |
---|---|---|---|---|---|---|---|---|
...FMEENE | 668 | inferred from cleavage | unknown | TopFIND | Inferred from cleavage TC19644 | |||
...FMEENE | 668 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt137917 | |||
...FMEENE | 668 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt138977 | |||
...EAFDLD | 1283 | inferred from cleavage | unknown | TopFIND | Inferred from cleavage TC19647 | |||
...EAFDLD | 1283 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt141185 | |||
...EAFDLD | 1283 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt141351 | |||
...CEDGAS | 1420 | inferred from electronic annotation | electronic annotation | UniProtKB | inferred from uniprot | |||
...CEDGAS | 1420 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt93747 | |||
...CEDGAS | 1420 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt93746 | |||
...MELWL | 1445 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt65464 | |||
...MELWL | 1445 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt65466 |
Cleavages
Protease | Position | Sequence | Evidence type | Method | Source (database) | Source (Lab) | Evidence name | Publications (PMIDs) |
---|---|---|---|---|---|---|---|---|
MEP1B_HUMAN | 668 | EENE.|.EGHI | inferred from experiment | unknown | MEROPS | Overall CM | Becker-Pauly C et al.:Proteomic analyses reveal an ac... (M12.002) | 21693781, |
MEP1B_HUMAN | 1283 | FDLD.|.DVAV | inferred from experiment | unknown | MEROPS | Overall CM | Becker-Pauly C et al.:Proteomic analyses reveal an ac... (M12.002) | 21693781, |
Substrates
Substrate | Position | Sequence | Evidence type | Method | Source (database) | Source (Lab) | Evidence name | Publications (PMIDs) |
---|